IL33 and Hepatic fibrosis: IL-33 is pro-fibrogenic, as its hepatic expression is sufficient to drive severe liver fibrosis through ILC2-derived IL-13; which is further demonstrated by a strong reduction of experimentally-induced liver fibrosis in mice lacking IL-33 [7].